Self-reported side effects in children and adolescents taking risperidone

REFERENCES

• Cheng-Shannon J, McGough MD, Pataki C, McCracken JT. Second-generation antipsychotic medications in children and adolescents. Journal of Child and Adolescent Psychopharmacology 2004; 14: 372–394.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Essential Psychopharmcology – The Prescribers Guide. New York: Cambridge University Press, 2006.
   Google Scholar
• Croonenberghs J, Fegert J, Findling RL, De Smedt G, van Dongen S. Rispiridone in children with disruptive behavior disorders and subaverage intelligence. A 1-year, open-label study of 504 patients. Journal of American Academy of Child and Adolescent Psychiatry 2005; 44: 64–72.
   PubMed Web of Science ®Google Scholar
• Reyes M, Olah R, Csaba K, Augustyns I, Eerdekens M. Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders: Results of a 2-year extension study. European Child and Adolescent Psychiatry 2005; 15: 97–104.
   Google Scholar
• Reyes M, Croonenberghs J, Augustyns I, Eerdekens M.Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety and tolerability. Journal of Child and Adolescent Psychopharmacology 2006; 16: 260–272.
   Web of Science ®Google Scholar
• Findling RL. Atypical antipsychotics in the treatment of children and adolescents. Journal of Clinical Psychiatry 2004; 65 (Suppl. 6): 3–29.
   Google Scholar
• Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 2006; 63: 679–685.
   PubMed Web of Science ®Google Scholar
• Silvaprasad L, Hassan T, Handy S. Survey of atypical antipsychotic medication used by children and adolescent psychiatrists. Child and Adolescent Mental Health 2006; 11: 164–167.
   Google Scholar
• Doey T, Handelman K, Seabrook JA, Steele M. Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patient age under 18 years. The Canadian Journal of Psychiatry. 2007; 52: 363–368.
   PubMed Web of Science ®Google Scholar
• Efron D, Hiscock H, Sewell JR, Cranswick NE, Vance AL, Tyl Y, Luk ESL. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 2003; 111: 372–375.
   PubMed Web of Science ®Google Scholar
• Correll CU. Metabolic side effects of second-generation antipsychotics in children and adolescents: A different story. Journal of Clinical Psychiatry 2005; 66: 1331–1332.
   PubMed Web of Science ®Google Scholar
• Correll CU. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of American Academy of Child and Adolescent Psychiatry 2006; 45: 771–791.
   PubMed Web of Science ®Google Scholar
• Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximise outcomes. Journal of American Academy of Child and Adolescent Psychiatry 2008; 47: 9–20.
   PubMed Web of Science ®Google Scholar
• Aman MG, Arnold E, McDougle CJ, . Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology 2005; 15: 869–884.
   PubMed Web of Science ®Google Scholar
• Linjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatrica Scandinavica 1987; 76: 1–100.
   Google Scholar
• Day JC, Wood G, Dewey M, Bentall RP.. A self-rating scale for measuring neuroleptic side effects – validation in a group of schizophrenic patients. British Journal of Psychiatry 1995; 166: 650–653.
   PubMed Web of Science ®Google Scholar
• Lambert TJR.. Measurement of antipsychotic-induced side effects: Support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Human Psychopharmacology 2003; 18: 405–411.
   PubMed Web of Science ®Google Scholar
• Jerrell JM, McIntyre RS. Adverse events in children and adolescents treated with antipsychotic medications. Human Psychopharmacology 2008; 23: 283–290.
   PubMed Web of Science ®Google Scholar
• Walter G, DeLaroche A, Soh N, . Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry 2008; 16: 253–262.
   PubMed Web of Science ®Google Scholar